A citation-based method for searching scientific literature


List of co-cited articles
966 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
918
24

Novel therapeutic targets in depression: minocycline as a candidate treatment.
Joanna K Soczynska, Rodrigo B Mansur, Elisa Brietzke, Walter Swardfager, Sidney H Kennedy, Hanna O Woldeyohannes, Alissa M Powell, Marena S Manierka, Roger S McIntyre. Behav Brain Res 2012
114
22

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
21


Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.
Jonathan B Savitz, T Kent Teague, Masaya Misaki, Matt Macaluso, Brent E Wurfel, Matt Meyer, Douglas Drevets, William Yates, Ondria Gleason, Wayne C Drevets,[...]. Transl Psychiatry 2018
69
23

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
J C O'Connor, M A Lawson, C André, M Moreau, J Lestage, N Castanon, K W Kelley, R Dantzer. Mol Psychiatry 2009
786
18

Minocycline: far beyond an antibiotic.
N Garrido-Mesa, A Zarzuelo, J Gálvez. Br J Pharmacol 2013
455
18

Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
Muhammad I Husain, Imran B Chaudhry, Nusrat Husain, Ameer B Khoso, Raza R Rahman, Munir M Hamirani, John Hodsoll, Inti Qurashi, John Fw Deakin, Allan H Young. J Psychopharmacol 2017
67
22

Depression as a microglial disease.
Raz Yirmiya, Neta Rimmerman, Ronen Reshef. Trends Neurosci 2015
385
18

Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.
Tsuyoshi Miyaoka, Rei Wake, Motohide Furuya, Kristian Liaury, Masa Ieda, Kazunori Kawakami, Keiko Tsuchie, Michiyo Taki, Kotomi Ishihara, Tomoko Araki,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2012
143
16

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
473
16

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.
Christopher J Henry, Yan Huang, Angela Wynne, Mark Hanke, Justin Himler, Michael T Bailey, John F Sheridan, Jonathan P Godbout. J Neuroinflammation 2008
427
15

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
13

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
518
13

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
13



Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
Olivia M Dean, Buranee Kanchanatawan, Melanie Ashton, Mohammadreza Mohebbi, Chee Hong Ng, Michael Maes, Lesley Berk, Atapol Sughondhabirom, Sookjaroen Tangwongchai, Ajeet B Singh,[...]. Aust N Z J Psychiatry 2017
51
21



Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression.
Nikita N Burke, Daniel M Kerr, Orla Moriarty, David P Finn, Michelle Roche. Brain Behav Immun 2014
106
12

A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo.
James W Murrough, Kathryn M Huryk, Xiangling Mao, Brian Iacoviello, Katherine Collins, Andrew A Nierenberg, Guoxin Kang, Dikoma C Shungu, Dan V Iosifescu. J Affect Disord 2018
27
37

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.
T Kreisel, M G Frank, T Licht, R Reshef, O Ben-Menachem-Zidon, M V Baratta, S F Maier, R Yirmiya. Mol Psychiatry 2014
362
12

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Muhammad Ishrat Husain, Imran B Chaudhry, Ameer B Khoso, Muhammad Omair Husain, John Hodsoll, Moin A Ansari, Haider A Naqvi, Fareed A Minhas, Andre F Carvalho, Jeffrey H Meyer,[...]. Lancet Psychiatry 2020
42
23


Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
Ole Kohler, Jesper Krogh, Ole Mors, Michael Eriksen Benros. Curr Neuropharmacol 2016
202
11

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial.
Maria Antonietta Nettis, Giulia Lombardo, Caitlin Hastings, Zuzanna Zajkowska, Nicole Mariani, Naghmeh Nikkheslat, Courtney Worrell, Daniela Enache, Anna McLaughlin, Melisa Kose,[...]. Neuropsychopharmacology 2021
42
21

Immune system to brain signaling: neuropsychopharmacological implications.
Lucile Capuron, Andrew H Miller. Pharmacol Ther 2011
640
10

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.
Yechiel Levkovitz, Shlomo Mendlovich, Sharon Riwkes, Yoram Braw, Hana Levkovitch-Verbin, Gilad Gal, Shmuel Fennig, Ilan Treves, Shmuel Kron. J Clin Psychiatry 2010
272
10

Antidepressant-like actions of minocycline combined with several glutamate antagonists.
Miguel Molina-Hernández, Norma Patricia Tellez-Alcántara, Julian Pérez-García, Jorge Ivan Olivera-Lopez, M Teresa Jaramillo-Jaimes. Prog Neuropsychopharmacol Biol Psychiatry 2008
92
10

A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
Joanna K Soczynska, Sidney H Kennedy, Mohammad Alsuwaidan, Rodrigo B Mansur, Madeline Li, Mary Pat McAndrews, Elisa Brietzke, Hanna O Woldeyohannes, Valerie H Taylor, Roger S McIntyre. Bipolar Disord 2017
28
28

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
198
10

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial.
Hamid Emadi-Kouchak, Payam Mohammadinejad, Ali Asadollahi-Amin, Mehrnaz Rasoulinejad, Atefeh Zeinoddini, Alireza Yalda, Shahin Akhondzadeh. Int Clin Psychopharmacol 2016
42
19

So depression is an inflammatory disease, but where does the inflammation come from?
Michael Berk, Lana J Williams, Felice N Jacka, Adrienne O'Neil, Julie A Pasco, Steven Moylan, Nicholas B Allen, Amanda L Stuart, Amie C Hayley, Michelle L Byrne,[...]. BMC Med 2013
638
10

Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.
Susana G Torres-Platas, Cristiana Cruceanu, Gary Gang Chen, Gustavo Turecki, Naguib Mechawar. Brain Behav Immun 2014
253
10

Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium.
Gara Arteaga-Henríquez, Maria S Simon, Bianka Burger, Elif Weidinger, Annemarie Wijkhuijs, Volker Arolt, Tom K Birkenhager, Richard Musil, Norbert Müller, Hemmo A Drexhage. Front Psychiatry 2019
54
14

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
528
8

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Lucile Capuron, Jane F Gumnick, Dominique L Musselman, David H Lawson, Andrea Reemsnyder, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2002
513
8

Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline.
Madeleine Hinwood, Ross J Tynan, Janine L Charnley, Sarah B Beynon, Trevor A Day, F Rohan Walker. Cereb Cortex 2013
193
8

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition.
M-L Wong, A Inserra, M D Lewis, C A Mastronardi, L Leong, J Choo, S Kentish, P Xie, M Morrison, S L Wesselingh,[...]. Mol Psychiatry 2016
244
8

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan, Alan A Wilson, Romina Mizrahi, Pablo M Rusjan, Laura Miler, Grazyna Rajkowska, Ivonne Suridjan, James L Kennedy, P Vivien Rekkas, Sylvain Houle,[...]. JAMA Psychiatry 2015
447
8

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment.
Imran B Chaudhry, Jaime Hallak, Nusrat Husain, Fareed Minhas, John Stirling, Paul Richardson, Serdar Dursun, Graham Dunn, Bill Deakin. J Psychopharmacol 2012
183
8


Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.
Ying-Qiang Xiang, Wei Zheng, Shi-Bin Wang, Xin-Hu Yang, Dong-Bin Cai, Chee H Ng, Gabor S Ungvari, Deanna L Kelly, Wei-Ying Xu, Yu-Tao Xiang. Eur Neuropsychopharmacol 2017
48
14

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial.
Bill Deakin, John Suckling, Thomas R E Barnes, Kelly Byrne, Imran B Chaudhry, Paola Dazzan, Richard J Drake, Annalisa Giordano, Nusrat Husain, Peter B Jones,[...]. Lancet Psychiatry 2018
72
9

Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
Marco Solmi, Nicola Veronese, Nita Thapa, Silvia Facchini, Brendon Stubbs, Michele Fornaro, André F Carvalho, Christoph U Correll. CNS Spectr 2017
41
17


Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline.
Shiho Arakawa, Yukihiko Shirayama, Yuko Fujita, Tamaki Ishima, Mao Horio, Katsumasa Muneoka, Masaomi Iyo, Kenji Hashimoto. Pharmacol Biochem Behav 2012
65
10

Does minocycline have antidepressant effect?
Chi-Un Pae, David M Marks, Changsu Han, Ashwin A Patkar. Biomed Pharmacother 2008
76
9

Treatment-resistant depression and peripheral C-reactive protein.
Samuel R Chamberlain, Jonathan Cavanagh, Peter de Boer, Valeria Mondelli, Declan N C Jones, Wayne C Drevets, Philip J Cowen, Neil A Harrison, Linda Pointon, Carmine M Pariante,[...]. Br J Psychiatry 2019
138
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.